Online Education Intervention to Reduce Ageism Among Undergraduate Students

May 3, 2021 updated by: Nadeeja Wijayatunga, University of Mississippi, Oxford

Effectiveness of an Online Educational Intervention to Reduce Ageism in Undergraduate Students in an Entry-level Nutrition Class

Ageism is common is healthcare workers, and that results in negative outcomes for elderly patients. This randomized controlled trial is to determine if age bias could be changed by an online learning activity in undergraduate students in an entry-level nutrition class.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

This randomized controlled trial with two parallel arms is to determine the effect of an online educational intervention developed to reduce ageism in undergraduate students enrolled in an entry-level Nutrition class. Eligible study participants will be randomized into either the "Intervention group" (INT) or the "Control group" (CON). The two groups will have different learning material delivered online via Blackboard (Learning Management System/LMS). These include a collection of short videos developed by the researchers, as well as relevant videos available on the web. Participants in the INT group will learn about aging and ageism, while the CON group will learn about diversity and cultural competence. Sociodemographic data, percieved risk of COVID-19, preventative behaviors related ot COVID-19 will be collected using a questionnaire at baseline. Ageism will be assessed using standard questionnaires. Data collection will be done at three time points: Pre-intervention, immediate post intervention and 2-weeks post-intervention. Difference between groups for pre-post intervention changes will be assessed.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
64

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Mississippi
      • Oxford, Mississippi, United States, 38677
        • University of Mississippi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 18 years or older
  • Enrolled in 3 sections of the introductory level nutrition course taught by three different instructors.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Intervention group (INT)
An online learning module targeted to reduce ageism will be delivered to the INT group.
Behavioral: Online educational intervention to reduce ageism
Participants in this group will go over multiple short videos covering the following content:1). Myths about aging, 2). Ageism and its negative effects, 3). Distorted views about aging among young adults, 4). Ageism during the COVID-19 pandemic, and 5). importance of reducing ageism among healthcare professionals. These will be multiple videos posted on the LMS (Blackboard). At the end of the lesson, they will be asked to briefly write what they learned on Blackboard as an assignment.
Active Comparator: Control group (CON)
An online learning module on diversity and cultural competence will be delivered to the CON group.
Behavioral: Online educational intervention to enhance cultural competance
Participants in the control group will go over multiple short videos covering the following content: 1). Myths about cultural competence, 2) Cultural competence for health care professionals including dietitians, 3). Connecting culture and food, and 4). Importance of cultural competence in sports dietitians. At the end of the lesson, they will be asked to briefly write what they learned. These will be multiple videos posted on the LMS (Blackboard). At the end of the lesson, they will be asked to briefly write what they learned on Blackboard as an assignment.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Difference between groups for pre-and post intervention changes in the score of Fraboni's Scale for Ageism
Time Frame: From Pre- to immediate post- intervention
Higher Fraboni's score indicates more bias.
From Pre- to immediate post- intervention
Difference between groups for pre- and 2-weeks post intervention changes in the score of Fraboni's Scale for Ageism
Time Frame: From Pre- to 2-weeks post-intervention
Higher Fraboni's score indicates more bias.
From Pre- to 2-weeks post-intervention
Difference between groups for pre-post intervention changes in benevolent subscores of the Ambivalent ageism scale
Time Frame: From Pre- to immediate post- intervention
Higher benevolent score indicates more benevolent ageism
From Pre- to immediate post- intervention
Difference between groups for pre and 2-weeks post intervention changes in benevolent subscores of the Ambivalent ageism scale Higher score indicates more benevolent bias.
Time Frame: From Pre- to 2-weeks post-intervention
Higher benevolent score indicates more benevolent ageism
From Pre- to 2-weeks post-intervention
Difference between groups for pre-post intervention changes in hostile subscores of the Ambivalent ageism scale
Time Frame: From Pre- to immediate post- intervention
Higher hostile score indicates more hostile ageism
From Pre- to immediate post- intervention
Difference between groups for pre and 2-week post intervention changes in hostile subscores of the Ambivalent ageism scale
Time Frame: From Pre- to 2-weeks post-intervention
Higher hostile score indicates more hostile ageism
From Pre- to 2-weeks post-intervention

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Time Frame
Difference between groups for pre-post intervention changes in age-related implicit bias
Time Frame: From Pre- to immediate post- intervention
From Pre- to immediate post- intervention
Difference between groups for pre and 2-week post intervention changes in age-related implicit bias
Time Frame: From Pre- to 2-weeks post-intervention
From Pre- to 2-weeks post-intervention
Difference between groups for pre-post intervention changes in the value (years) used to define "old age"
Time Frame: From Pre- to immediate post- intervention
From Pre- to immediate post- intervention
Difference between groups for pre and 2-weeks post intervention changes in the value (years) used to define "old age"
Time Frame: From Pre- to 2-weeks post-intervention
From Pre- to 2-weeks post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University of Mississippi, Oxford

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Nadeeja Wijayatunga, PhD, Assistant Professor, Department of Nutrition and Hospitality Management

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 28, 2020

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
November 11, 2020

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
November 11, 2020

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
September 25, 2020

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 25, 2020

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 30, 2020

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 6, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 3, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2020

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 21x-046

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

We will share the de-identified data on ICPSR database

IPD Sharing Time Frame

Within 6 months time after the publication of the primary and secondary analysis planned.

IPD Sharing Access Criteria

Public access database

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ageism

Clinical Trials on Online educational intervention to reduce ageism

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings